| GA20862-25mg |
|
69644-78-6 |
|
0 |
C28H48N6O12S2 |
|
|
|
| GA20861-25mg |
|
131104-10-4 |
Biotinyl-ε-aminocaproyl-D-Phe-Pro-Arg-chloromethylketone
|
0 |
C37H56ClN9O6S |
|
|
|
| GA20861-5mg |
|
131104-10-4 |
Biotinyl-ε-aminocaproyl-D-Phe-Pro-Arg-chloromethylketone
|
0 |
C37H56ClN9O6S |
|
|
|
| GA20860-1mg |
|
151928-23-3 |
Biotinyl-εAhx-ω-Conotoxin GVIA
|
0 |
C136H207N41O46S7 |
|
|
|
| GA20860-005mg |
|
151928-23-3 |
Biotinyl-εAhx-ω-Conotoxin GVIA
|
0 |
C136H207N41O46S7 |
|
|
|
| GA20859-005mg |
|
455951-99-2 |
Biotinyl-εAhx-SCC1 (263-268)-2,4,6-trimethylbenzoyloxy-methylketone (S. cerevisiae)
|
0 |
C53H83N13O15S |
|
|
|
| GA20859-001mg |
|
455951-99-2 |
Biotinyl-εAhx-SCC1 (263-268)-2,4,6-trimethylbenzoyloxy-methylketone (S. cerevisiae)
|
0 |
C53H83N13O15S |
|
|
|
| GA20858-1g |
|
72040-64-3 |
|
0 |
C16H27N3O4S |
|
|
|
| GA20857-1mg |
|
2022972-72-9 |
Biotinyl-εAhx-LL-37 (scrambled)
|
0 |
C221H365N63O56S |
|
|
|
| GA20857-005mg |
|
2022972-72-9 |
Biotinyl-εAhx-LL-37 (scrambled)
|
0 |
C221H365N63O56S |
|
|
|
| GA20856-1mg |
|
2022956-45-0 |
Biotinyl-εAhx-Gly-Arg-Gly-Asp-Ser-OH
|
0 |
C33H55N11O12S |
|
|
|
| GA20856-005mg |
|
2022956-45-0 |
Biotinyl-εAhx-Gly-Arg-Gly-Asp-Ser-OH
|
0 |
C33H55N11O12S |
|
|
|
| GA20855-005mg |
|
— |
Biotinyl-εAhx-Amyloid β-Protein (1-42)
|
0 |
C219H336N58O63S2 |
|
|
|
| GA20855-001mg |
|
— |
Biotinyl-εAhx-Amyloid β-Protein (1-42)
|
0 |
C219H336N58O63S2 |
|
|
|
| GA20854-005mg |
|
1802086-72-1 |
Biotinyl-εAhx-Amyloid β-Protein (1-40)
|
0 |
C210H320N56O61S2 |
|
|
|
| GA20854-001mg |
|
1802086-72-1 |
Biotinyl-εAhx-Amyloid β-Protein (1-40)
|
0 |
C210H320N56O61S2 |
|
|
|
| GA20853-005mg |
|
1816258-61-3 |
Biotinyl-α-CGRP (mouse, rat)
|
0 |
C172H276N52O54S3 |
|
|
|
| GA20852-1mg |
|
1816258-60-2 |
|
0 |
C173H281N53O51S3 |
|
|
|
| GA20852-005mg |
|
1816258-60-2 |
|
0 |
C173H281N53O51S3 |
|
|
|
| GA20851-005mg |
|
1815618-13-3 |
Biotinyl-VIP (human, mouse, rat)
|
0 |
C157H252N46O44S2 |
|
|
|
